Unity Software Inc vs Zoetis Inc — how do they compare? Unity Software Inc trades at $46.57 (market cap $20.20B), while Zoetis Inc trades at $74.52 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays a 2.9% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Unity Software Inc for 50 Days and Zoetis Inc for 70 Days on average.
| U | ZTS | |
|---|---|---|
Market Cap | $20.20B | $30.20B |
Volume | 15,432,191 | 6,175,327 |
Sector | Technology | Health |
52-Week High | $49.47 | $147.53 |
52-Week Low | $17.13 | $69.09 |
Typical Hold Time | 50 Days | 70 Days |
Enterprise Value | $20.08B | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
Unity Software (U) trades at $45.44, up 1.09% on the day, with a bullish technical signal and strong analyst support. The stock is near its pivot point of $45, with immediate resistance at $46. Fundamentally, revenue reached $1.85B in 2025, but the company reported a net loss of -$402.77M, though losses are narrowing year-over-year. Recent news highlights momentum from Meta VR Glasses support and positive sector sentiment.
Outlook: Strong buy consensus (82% of analysts) and a $46.54 price target suggest upside, but persistent losses and high valuation ratios pose risks. Investment appeal hinges on revenue growth and path to profitability, while competitive and execution risks remain key concerns for investors.
Zoetis (ZTS) trades at $71.55, showing modest daily gains of 0.32% amid a challenging market environment. The stock faces bearish technical signals with mixed earnings performance, having beaten estimates in Q2 2026 but missing in Q1. Despite recent headwinds in U.S. companion animal sales, the company maintains strong profitability with 71.67% gross margins and 27.69% net income margins. Analyst consensus remains positive with a $87.33 price target, though technical indicators suggest near-term pressure with support at $70-$71.
Zoetis presents a compelling value opportunity with attractive valuation multiples (P/E 11.92, EV/EBITDA 9.4) and robust fundamentals, though near-term risks include competitive pressures in pet medications and weakening U.S. veterinary clinic traffic. The company's international and livestock segments show resilience, supporting long-term growth potential despite current market skepticism.
Trailing returns across standard periods
Latest headlines on both assets
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →